查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1654292

白血球分离术市场规模、份额、趋势分析报告（按产品类型、应用、最终用途、地区、细分市场预测），2025 年至 2030 年

Leukapheresis Market Size, Share & Trends Analysis Report By Product Type (Leukapheresis Devices, Leukapheresis Disposables), By Application (Research Application, Therapeutic Application), By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

白血球分离术的市场规模与趋势：

2024 年全球白血球分离术市场规模估计为 2.113 亿美元，预计 2025 年至 2030 年期间复合年增长率为 11.05%。

血液疾病和自体免疫疾病盛行率的上升、白血球分离术输血程序的技术进步以及个人化医疗的需求不断增长预计将推动市场成长。此外，增加对研发活动的投资也进一步促进了市场的成长。

白血病、淋巴瘤等血液疾病以及类风湿性关节炎和多发性硬化症等自体免疫疾病的发生率不断上升，大大推动了市场的成长。例如，白血病和淋巴瘤协会报告称，预计 2023 年美国将总合184,720 人被诊断出患有白血病、淋巴瘤和骨髓瘤。同样，2023年5月，《柳叶刀》杂誌对2200万人进行的一项研究表明，每10人中就有1人患有自体免疫疾病，这凸显了社会经济、季节和地理因素的影响，并深入了解了这些疾病的病因，其中包括类风湿性关节炎、1型糖尿病和多发性硬化症。因此，在预测期内将推动对白血球分离术的需求。

白血球分离术输血技术的进步提高了此手术的效率、安全性和效果。自动化系统、连续流离心系统和封闭式系统设备的引入有望提高白血球分离术的准确性和有效性。这缩短了手术时间，最大限度地减少了捐赠者的不适，并优化了细胞收集产量。 2022 年 10 月，美国血液分离学会 (ASFA) 临床应用委员会与 IEC 治疗小组委员会、AABB 和其他组织一起制定了一份白皮书。该文件概述了进行白血球分离术的指导方针，白血球分离术是从儿童和成人患者体内采集单核细胞作为免疫效应细胞疗法的一部分，无论是在商业性还是研究倡议中。因此，预计它将在预测期内推动市场成长。

个人化医疗方法的转变，即根据个别患者的状况制定治疗策略，正在推动对白血球分离疗法的需求。白血球清洗在嵌合体抗原受体（CAR）T细胞治疗和干细胞移植等细胞治疗中起着关键作用。 2023 年 12 月发表在《输血与血液分离科学》杂誌上的一篇论文强调了製造 CAR-T 细胞的挑战，製造过程首先要从週边血液中收集白血球。论文强调了有效收集白血球对于CAR-T细胞治疗成功的关键作用，并强调了了解影响T细胞品质的因素的重要性。

目录

第一章调查方法与范围

第 2 章执行摘要

3. 白血球分离术市场变数、趋势与范围

  • 市场展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 白血球分离术市场分析工具
    • 产业分析-波特五力分析
    • PESTEL 分析
    • COVID-19影响分析

第四章 白血球去除市场：产品类型估计与趋势分析

  • 细分仪表板
  • 全球白血球成分分析市场产品类型变化分析
  • 2018 年至 2030 年全球白血球分析市场规模及趋势分析（依产品类型）
  • 白血球去除装置
    • 离心分离机
    • 膜分离设备
  • 去除白血球一次性用品

第五章 白血球去除市场：应用评估与趋势分析

  • 细分仪表板
  • 全球白血球成分分析市场应用变迁分析
  • 2018 年至 2030 年全球白血球分析市场规模及趋势分析（按应用）
  • 研究用途
    • 癌症研究
    • 免疫学研究
    • 其他的
  • 治疗用途
    • 血液系统疾病
    • 自体免疫疾病
    • 其他的

第六章 白血球减少市场：最终用途估计与趋势分析

  • 细分仪表板
  • 全球白血球分析市场最终用途变异分析
  • 2018 年至 2030 年全球白血球分析市场规模及趋势分析（依最终用途）
  • 血液中心
  • 学术研究所
  • 製药和生物技术公司
  • 医院和诊所

第 7 章 白血球去除市场：按产品类型、应用和最终用途进行的区域估计和趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2018 年至 2030 年市场规模及预测趋势分析：
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 公司/竞争对手分类
  • 战略地图
  • 2024 年企业市场分析
  • 公司简介/上市公司
    • Charles River Laboratories International, Inc.
    • Adacyte Therapeutics
    • AllCells, LLC
    • Asahi Kasei Medical
    • Haemonetics Corporation
    • Macopharma
    • Cerus Corporation
    • SB-Kawasumi Laboratories, Inc.
    • StemExpress, LLC.
    • Caltag Medsystems Limited
    • Lonza Group AG
    • ZenBio
    • Terumo BCT, Inc.
    • Macopharma SA
    • Miltenyi Biotec
    • Fresenius SE &Co. KGaA
    • Guangzhou Daji Medical Science
    • MEDICA SpA
    • SB-Kawasumi Laboratories, Inc.
    • PuriBlood Medical Co. Ltd.
    • Beijing ZKSK Technology Co. Ltd.
Product Code: GVR-4-68040-357-9

Leukapheresis Market Size & Trends:

The global leukapheresis market size was estimated at USD 211.3 million in 2024 and is projected to grow at a CAGR of 11.05% from 2025 to 2030. The increasing prevalence of blood disorders and autoimmune diseases, technological advancements in leukapheresis procedures, and growing demand for personalized medicine are expected to drive the market growth. Moreover, the increasing investments in research and development activities are further contributing to the market growth.

The rising incidence of blood disorders like leukemia, lymphoma, and autoimmune diseases such as rheumatoid arthritis and multiple sclerosis are significantly driving the market growth. For instance, the Leukemia & Lymphoma Society reports that an estimated total of 184,720 people in the U.S. are expected to receive a diagnosis of leukemia, lymphoma, or myeloma in 2023. Similarly, in May 2023, a study in The Lancet involving 22 million people found autoimmune disorders affect 1 in 10 individuals, highlighting the influence of socioeconomic, seasonal, and regional factors and offers insights into the causes of these diseases, including Rheumatoid arthritis, Type 1 diabetes, and Multiple sclerosis. Thus, propelling the demand for leukapheresis over the forecast period.

The advancements in leukapheresis technologies are improving the efficiency, safety, and outcomes of the procedure. The introduction of automated systems, continuous flow centrifugation systems, and closed-system devices is expected to enhance the precision and effectiveness of leukapheresis. Thereby reducing the procedure times, minimizing donor discomfort, and optimizing cell collection yields. In October 2022, the Clinical Applications Committee of The American Society for Apheresis (ASFA), along with the IEC Therapy Subcommittee, AABB, and various other organizations, prepared a white paper. This document outlines guidelines for performing leukapheresis to retrieve mononuclear cells from pediatric and adult patients who are part of immune effector cell therapies, whether for commercial endeavors or research initiatives. Thus, anticipated to propel the market growth over the forecast period.

The shift towards personalized medicine approaches that tailor treatment strategies to individual patient profiles is fueling the demand for leukapheresis procedures. Leukapheresis plays a crucial role in cell-based therapies, such as chimeric antigen receptor (CAR) T-cell therapy and stem cell transplantation. In December 2023, an article in Transfusion and Apheresis Science underscored the challenges in manufacturing CAR-T cells, beginning with the extraction of T cells through leukapheresis from peripheral blood. The article emphasized the critical role of an effective leukapheresis product in achieving successful CAR-T cell therapy and highlighted the significance of comprehending the factors that impact T cell quality.

Global Leukapheresis Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global leukapheresis market report based on product type, application, end-use, and region:

  • Product Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Leukapheresis Devices
    • Centrifugal Devices
    • Membrane Separators
  • Leukapheresis Disposables
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Research Application
    • Cancer Research
    • Immunology Research
    • Others
  • Therapeutics Application
    • Hematologic Disorders
    • Autoimmune Diseases
    • Others
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Blood Centers
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Clinics
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Type
    • 1.2.2. Application
    • 1.2.3. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Leukapheresis Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. The increasing prevalence of blood disorders and autoimmune diseases
      • 3.2.1.2. Technological advancements in leukapheresis procedures
      • 3.2.1.3. Growing demand for personalized medicine
      • 3.2.1.4. Rising investments in research
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High equipment costs
  • 3.3. Leukapheresis Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Leukapheresis Market: Product Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Leukapheresis Market Product Type Movement Analysis
  • 4.3. Global Leukapheresis Market Size & Trend Analysis, by Product Type, 2018 to 2030 (USD Million)
  • 4.4. Leukapheresis Devices
    • 4.4.1. Leukapheresis devices market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Centrifugal Devices
      • 4.4.2.1. Centrifugal Devices market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Membrane Separators
      • 4.4.3.1. Membrane separators market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Leukapheresis Disposables
    • 4.5.1. Leukapheresis disposables market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Leukapheresis Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Leukapheresis Market Application Movement Analysis
  • 5.3. Global Leukapheresis Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Research Application
    • 5.4.1. Research application market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.2. Cancer Research
      • 5.4.2.1. Cancer research market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.3. Immunology Research
      • 5.4.3.1. Immunology research market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.4. Others
      • 5.4.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Therapeutics Application
    • 5.5.1. Therapeutics application market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.5.2. Hematologic Disorders
      • 5.5.2.1. Hematologic disorders market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.5.3. I Autoimmune Diseases
      • 5.5.3.1. Autoimmune diseases market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.5.4. Others
      • 5.5.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Leukapheresis Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Leukapheresis Market End Use Movement Analysis
  • 6.3. Global Leukapheresis Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Blood Centers
    • 6.4.1. Blood centers institutes market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Academic & Research Institutes
    • 6.5.1. Academic & research institutes market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Pharmaceutical & Biotechnology Companies
    • 6.6.1. Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7. Hospitals & Clinics
    • 6.7.1. Hospitals & clinics market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Leukapheresis Market: Regional Estimates & Trend Analysis by Product Type, Application, and End Use

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Regulatory framework
      • 7.5.8.3. Competitive scenario
      • 7.5.8.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.9. Denmark
      • 7.5.9.1. Key country dynamics
      • 7.5.9.2. Regulatory framework
      • 7.5.9.3. Competitive scenario
      • 7.5.9.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework
      • 7.8.4.3. Competitive scenario
      • 7.8.4.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key country dynamics
      • 7.8.5.2. Regulatory framework
      • 7.8.5.3. Competitive scenario
      • 7.8.5.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. Charles River Laboratories International, Inc.
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Adacyte Therapeutics
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. AllCells, LLC
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Asahi Kasei Medical
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Haemonetics Corporation
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Macopharma
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Cerus Corporation
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. SB-Kawasumi Laboratories, Inc.
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. StemExpress, LLC.
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Caltag Medsystems Limited
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives
    • 8.4.11. Lonza Group AG
      • 8.4.11.1. Company overview
      • 8.4.11.2. Financial performance
      • 8.4.11.3. Product benchmarking
      • 8.4.11.4. Strategic initiatives
    • 8.4.12. ZenBio
      • 8.4.12.1. Company overview
      • 8.4.12.2. Financial performance
      • 8.4.12.3. Product benchmarking
      • 8.4.12.4. Strategic initiatives
    • 8.4.13. Terumo BCT, Inc.
      • 8.4.13.1. Company overview
      • 8.4.13.2. Financial performance
      • 8.4.13.3. Product benchmarking
      • 8.4.13.4. Strategic initiatives
    • 8.4.14. Macopharma SA
      • 8.4.14.1. Company overview
      • 8.4.14.2. Financial performance
      • 8.4.14.3. Product benchmarking
      • 8.4.14.4. Strategic initiatives
    • 8.4.15. Miltenyi Biotec
      • 8.4.15.1. Company overview
      • 8.4.15.2. Financial performance
      • 8.4.15.3. Product benchmarking
      • 8.4.15.4. Strategic initiatives
    • 8.4.16. Fresenius SE & Co. KGaA
      • 8.4.16.1. Company overview
      • 8.4.16.2. Financial performance
      • 8.4.16.3. Product benchmarking
      • 8.4.16.4. Strategic initiatives
    • 8.4.17. Guangzhou Daji Medical Science
      • 8.4.17.1. Company overview
      • 8.4.17.2. Financial performance
      • 8.4.17.3. Product benchmarking
      • 8.4.17.4. Strategic initiatives
    • 8.4.18. MEDICA S.p.A
      • 8.4.18.1. Company overview
      • 8.4.18.2. Financial performance
      • 8.4.18.3. Product benchmarking
      • 8.4.18.4. Strategic initiatives
    • 8.4.19. SB-Kawasumi Laboratories, Inc.
      • 8.4.19.1. Company overview
      • 8.4.19.2. Financial performance
      • 8.4.19.3. Product benchmarking
      • 8.4.19.4. Strategic initiatives
    • 8.4.20. PuriBlood Medical Co. Ltd.
      • 8.4.20.1. Company overview
      • 8.4.20.2. Financial performance
      • 8.4.20.3. Product benchmarking
      • 8.4.20.4. Strategic initiatives
    • 8.4.21. Beijing ZKSK Technology Co. Ltd.
      • 8.4.21.1. Company overview
      • 8.4.21.2. Financial performance
      • 8.4.21.3. Product benchmarking
      • 8.4.21.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global leukapheresis market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 4 Global leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 6 North America leukapheresis market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 8 North America leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 9 North America leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 10 U.S. leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 11 U.S. leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 12 U.S. leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 14 Canada leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 15 Canada leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Mexico leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 17 Mexico leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 18 Mexico leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe leukapheresis market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 21 Europe leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 22 Europe leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Germany leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 24 Germany leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 25 Germany leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 26 UK leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 27 UK leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 28 UK leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 29 France leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 30 France leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 31 France leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 33 Italy leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 34 Italy leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Spain leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 36 Spain leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 37 Spain leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Denmark leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 39 Denmark leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 40 Denmark leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Sweden leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 42 Sweden leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 43 Sweden leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Norway leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 45 Norway leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 46 Norway leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific leukapheresis market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 51 China leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 52 China leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 53 China leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Japan leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 55 Japan leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 56 Japan leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 57 India leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 58 India leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 59 India leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 60 South Korea leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 61 South Korea leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 62 South Korea leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 63 Australia leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 64 Australia leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 65 Australia leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Thailand leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 67 Thailand leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 68 Thailand leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Latin America leukapheresis market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 71 Latin America leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 72 Latin America leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Brazil leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 74 Brazil leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 75 Brazil leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Argentina leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 77 Argentina leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 78 Argentina leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 79 MEA leukapheresis market, by country, 2018 - 2030 (USD Million)
  • Table 80 MEA leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 81 MEA leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 82 MEA leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 83 South Africa leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 84 South Africa leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 85 South Africa leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 89 UAE leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 90 UAE leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 91 UAE leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 93 Kuwait leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 94 Kuwait leukapheresis market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Leukapheresis market: Market outlook
  • Fig. 5 Leukapheresis market: Segment outlook
  • Fig. 6 Leukapheresis market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Leukapheresis market driver impact
  • Fig. 9 Leukapheresis market restraint impact
  • Fig. 10 Leukapheresis market: Product type outlook and key takeaways
  • Fig. 11 Leukapheresis market: Product type movement analysis
  • Fig. 12 Leukapheresis devices market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 13 Centrifugal devices market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 Membrane separators market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Leukapheresis disposables market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Leukapheresis market: Application outlook and key takeaways
  • Fig. 17 Leukapheresis market: Application movement analysis
  • Fig. 18 Research application market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Cancer research market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Immunology research market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Therapeutics application market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 23 Hematologic disorders market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 24 Autoimmune diseases market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 25 Others market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 26 Leukapheresis market: End use outlook and key takeaways
  • Fig. 27 Leukapheresis market: End use movement analysis
  • Fig. 28 Blood centers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Pharmaceutical & biotechnology companies market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 31 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Global leukapheresis market: Regional outlook and key takeaways
  • Fig. 33 Global leukapheresis market: Regional movement analysis
  • Fig. 34 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)